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Many combinations of ring structures and
sensitizing groups have been synthesized and tested
for potential use as radiotherapy adjuvants to
overcome the resistance of hypoxic tumour cells to
ionizing radition. Among the drugs tested have
been nitroxyl compounds Cooke et al. (1976),
nitrofurans Chapman et al. (1973), nitropyrroles
Raleigh et al. (1978), nitroimidazoles Asquith et al.
(1974), non-nitro compounds Wardman et al.
(1982), and indoles Infante et al. (1980). Of the
compounds examined, misonidazole (MISO) and
desmethylmisonidazole, have entered clinical trials,
but optimal doses of drug with each radiation dose
fraction are not possible due to a cumulative
neurotoxicity.
MISO mimics oxygen and functions as a
radiosensitizer because of its electron affinity; this is
the so-called "rapid" component of biological
sensitization Adams, (1982). A prolonged
incubation of MISO under hypoxia leads to the
depletion of cellular thiols and results in an
additional component of radiosensitization (the
biological "slow" component) as well as a
sensitization to some chemotherapy agents
Stratford et al. (1980). The extent to which MISO
and other similar compounds produce the
preincubation effects correlates well with the
amount of cell killing produced, i.e. the
chemosensitization from prolonged hypoxic
incubation is linked inexorably with cytotoxicity.
In the search for compounds superior to MISO,
it might prove fruitful to consider separately the
requirements for radiosensitization and
chemosensitization. In the case of
chemosensitization a compound is needed that
reacts rapidly to deplete cellular thiols. In this case
hypoxic cell cytotoxicity is probably unavoidable,
although we do not know whether there is either a
direct link, or even a one-to-one correlation,
between cytotoxicity in the petri dish and the
troublesome dose-limiting neurotoxicity in the
human. For radiosensitization alone, a compound
showing minimal cytotoxicity may be advantageous
which could then be used at much higher
concentrations. This is the approach used in the
development of the triazole (1-methyl-3-nitro-1,2,4
triazole 3-NTR), tested in this report.
Chinese hamster V79 cells grown in Ham's FIO
supplemented with 10% foetal bovine serum,
antibiotics and L-glutamine were used in this study.
The procedure for the treatment of cells has been
described previously. Briefly, log phase cells grown
in Corning 150cm2 tissue culture flasks were
trypsinized and resuspended in complete growth
medium. Aerated and hypoxic cells at a
concentration of 2x105 cellsml-l were treated in
glass spinner vessels based on the design of
Chapman et al., 1974. Hypoxia was induced by
degassing with high purity N2 for a period of 1 h,
followed by addition of degassed drug to obtain the
desired final drug and cell concentration. The cells
were then incubated at 37.5°C for 1 h with drug
prior to irradiation or samples removed at desired
intervals for cytotoxicity determinations. Aliquots
were plated into flasks with fresh medium,
incubated for 7 days and fixed and stained.
The X-ray source was a Sieman's Stabilipan;
300kVp, 12mA, 0.2mm Cu; based on measurement
with a Victoreen ionization chamber, the dose-rate
at the treatment distance of 25 cm was calculated to
be 6.3 Gymin-1.
Data in Figure 1 bare from a representative
experiment in which hypoxic or aerated V79 cells
were treated with drug at 37.5°C for a period of 1 h
and during the immediately following exposure to
graded doses of X-rays. Figure 2 comprises pooled
data from several experiments (including those in
Figure 1) expressing the enhancement ratio (ER) as
a function of drug concentration. ER is defined as
the ratio of doses for cells treated under hypoxic
conditions without drug to hypoxic cells treated
with drug to obtain an equal biological effect.
Survival data for hypoxic or aerated V79 cells
treated at 37.5°C with 3-NTR are shown in Figure
3.
The data show that 3-NTR is a very efficient
radiosensitizer, specific for hypoxic cells, needing
approximately one-half the concentration of MISO
to obtain an equal ER. Furthermore, 3-NTR at the
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Figure 1 Representative radiation survival data for
hypoxic and aerated V79 cells treated with various
concentrations of 3-NTR for a period of 1 h at 37.5°C
prior to exposure to graded doses of X-rays. The
curves were fitted to the data by eye.
3.0
0 *° 2.5-
E 2.0-
u1 3-NTR /
Misonidazole
l-2 10-1 100 lo'
Drug concentration (mm)
Figure 2 The enhancement tatio (ER) as a function
of the concentration for the drugs 3-NTR and MISO.
The results are data pooled from several experiments.
highest dose tested, exhibited no significant toxicity
towards either aerated or hypoxic cells.
This communication presents new data in the
search for an alternative compound for use as an
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Figure 3 Cell survival data for hypoxic and aerated
V79 Chinese hamster cells incubated at 37.50C in the
presence of 3-NTR or MISO.
adjuvant to radiotherapy. The sensitizing efficiency
of aromatic nitro compounds is directly correlated
with their electron affinity. These properties are
commonly increased by introducing electron
withdrawing substituents on the ring. A second
method to decrease the It-density of a heterocyclic
system is to incorporate into the ring system a
pyridine type (X-deficient) nitrogen. This would
exert approximately the same electron withdrawing
effect as the introduction of an electron affinic
substituent. Indeed, 3-NTR exhibits approximately
a 100-fold increase in sensitizing efficiency over the
corresponding 4-nitroimidazole, Adams et al. (1979).
This compound and related analogues merit further
testing using in vivo systems to ascertain whether
these structures posses the requisite
pharmacological stability for use in vivo.
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